Direct detection of structurally resolved dynamics in a multiconformation receptor-ligand complex.

Structure-based drug design relies on static protein structures despite significant evidence for the need to include protein dynamics as a serious consideration. In practice, dynamic motions are neglected because they are not understood well enough to model, a situation resulting from a lack of explicit experimental examples of dynamic receptor-ligand complexes. Here, we report high-resolution details of pronounced ~1 ms time scale motions of a receptor-small molecule complex using a combination of NMR and X-ray crystallography. Large conformational dynamics in Escherichia coli dihydrofolate reductase are driven by internal switching motions of the drug-like, nanomolar-affinity inhibitor. Carr-Purcell-Meiboom-Gill relaxation dispersion experiments and NOEs revealed the crystal structure to contain critical elements of the high energy protein-ligand conformation. The availability of accurate, structurally resolved dynamics in a protein-ligand complex should serve as a valuable benchmark for modeling dynamics in other receptor-ligand complexes and prediction of binding affinities.

[1]  Peter E Wright,et al.  Defining the role of active-site loop fluctuations in dihydrofolate reductase catalysis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Boehr,et al.  An NMR perspective on enzyme dynamics. , 2006, Chemical reviews.

[3]  John T. Powers,et al.  Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors , 2010, Nature.

[4]  K. Dill,et al.  Binding of small-molecule ligands to proteins: "what you see" is not always "what you get". , 2009, Structure.

[5]  A. Palmer,et al.  NMR characterization of the dynamics of biomacromolecules. , 2004, Chemical reviews.

[6]  S. Teague.  Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.

[7]  S J Oatley,et al.  Crystal structures of Escherichia coli dihydrofolate reductase: the NADP+ holoenzyme and the folate.NADP+ ternary complex. Substrate binding and a model for the transition state. , 1990, Biochemistry.

[8]  Min Zhao,et al.  Coupling of Receptor Conformation and Ligand Orientation Determine Graded Activity , 2010, Nature chemical biology.

[9]  D. A. Bosco,et al.  Enzyme Dynamics During Catalysis , 2002, Science.

[10]  Arthur Christopoulos,et al.  Allosteric modulation of G protein-coupled receptors. , 2007, Annual review of pharmacology and toxicology.

[11]  Wolfgang Jahnke,et al.  Solution Conformations and Dynamics of ABL Kinase-Inhibitor Complexes Determined by NMR Substantiate the Different Binding Modes of Imatinib/Nilotinib and Dasatinib*♦ , 2008, Journal of Biological Chemistry.

[12]  H. Dyson,et al.  Diagnostic chemical shift markers for loop conformation and substrate and cofactor binding in dihydrofolate reductase complexes , 2003, Protein science : a publication of the Protein Society.

[13]  R. Friesner,et al.  Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.

[14]  A. Wand,et al.  Conformational entropy in molecular recognition by proteins , 2007, Nature.

[15]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[16]  Somesh D. Sharma,et al.  Managing protein flexibility in docking and its applications. , 2009, Drug discovery today.

[17]  C. Craik,et al.  Trapping Moving Targets with Small Molecules , 2009, Science.

[18]  Shaomeng Wang,et al.  A systematic analysis of the effect of small-molecule binding on protein flexibility of the ligand-binding sites. , 2005, Journal of medicinal chemistry.

[19]  E. Brown,et al.  High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate. , 2003, Bioorganic & medicinal chemistry letters.

[20]  L. Kuyper,et al.  X-ray Crystallographic Studies of Candida albicans Dihydrofolate Reductase , 1997, The Journal of Biological Chemistry.

[21]  Frederick W. Dahlquist,et al.  Studying excited states of proteins by NMR spectroscopy , 2001, Nature Structural Biology.

[22]  Charles L. Brooks III,et al.  Functionally important conformations of the Met20 loop in dihydrofolate reductase are populated by rapid thermal fluctuations. , 2009, Journal of the American Chemical Society.

[23]  J. Kraut,et al.  Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. , 1997, Biochemistry.

[24]  L. Kay,et al.  Reconstructing NMR spectra of "invisible" excited protein states using HSQC and HMQC experiments. , 2002, Journal of the American Chemical Society.

[25]  Andrew L. Lee,et al.  Dynamic dysfunction in dihydrofolate reductase results from antifolate drug binding: modulation of dynamics within a structural state. , 2009, Structure.

[26]  P Ghanouni,et al.  Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic Receptor* , 2001, The Journal of Biological Chemistry.

[27]  D. Boehr,et al.  The Dynamic Energy Landscape of Dihydrofolate Reductase Catalysis , 2006, Science.

[28]  L. Moore,et al.  The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity , 2001, Science.

[29]  Stephen H Hughes,et al.  High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations , 2008, Proceedings of the National Academy of Sciences.

[30]  G. Wider,et al.  Measuring protein concentrations by NMR spectroscopy. , 2006, Journal of the American Chemical Society.

[31]  Mark Embrey,et al.  A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J Andrew McCammon,et al.  Discovery of a novel binding trench in HIV integrase. , 2004, Journal of medicinal chemistry.

[33]  Xavier Deupi,et al.  Conformational complexity of G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.

[34]  Bruce A. Johnson,et al.  NMR View: A computer program for the visualization and analysis of NMR data , 1994, Journal of biomolecular NMR.

[35]  J. P. Loria,et al.  Evidence for flexibility in the function of ribonuclease A. , 2002, Biochemistry.

[36]  Debasis Mallik,et al.  A 2.13 A structure of E. coli dihydrofolate reductase bound to a novel competitive inhibitor reveals a new binding surface involving the M20 loop region. , 2006, Journal of medicinal chemistry.

[37]  L F Kuyper,et al.  X-Ray crystal structures of Candida albicans dihydrofolate reductase: high resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitor. , 2001, Journal of medicinal chemistry.

[38]  D. Ollis,et al.  Directed evolution of trimethoprim resistance in Escherichia coli , 2007, The FEBS journal.

[39]  C D Kroenke,et al.  Nuclear magnetic resonance methods for quantifying microsecond-to-millisecond motions in biological macromolecules. , 2001, Methods in enzymology.

[40]  D. Rich,et al.  Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles. , 2002, Journal of medicinal chemistry.

[41]  Rafael Najmanovich,et al.  Side‐chain flexibility in proteins upon ligand binding , 2000, Proteins.

[42]  Jeffrey W. Peng,et al.  Communication breakdown: protein dynamics and drug design. , 2009, Structure.

[43]  R. Powers,et al.  Impact of mobility on structure-based drug design for the MMPs. , 2002, Journal of the American Chemical Society.

[44]  Peter E Wright,et al.  Structure, dynamics, and catalytic function of dihydrofolate reductase. , 2004, Annual review of biophysics and biomolecular structure.